Director, CMC Project Leadership jobs in United States
cer-icon
Apply on Employer Site
company-logo

Fusion Pharmaceuticals · 1 week ago

Director, CMC Project Leadership

Fusion Pharmaceuticals is a clinical-stage oncology company focused on developing next-generation radioconjugates as precision medicines. The Director, CMC Project Leadership will lead CMC efforts for the lead asset, FPI-2265, and represent CMC on the Global Program team, ensuring effective development and commercialization of new medicines.

BiopharmaBiotechnologyMedicalOncologyPharmaceutical
Hiring Manager
Steve Downing
linkedin

Responsibilities

Has overall accountabilìty for defining and delivering the pharmaceutical development strategy that delivers effective development, approval, commercialization and LCM of new medicines
The key CMC accountabilities include
1. The overall development and technical strategy
2. The regulatory strategy and documentation for marketing authorizations (incl IND/IMPD)
3. For in-market products, the role holder is accountable for the development and delivery of the Manufacturability Strategy & Plan
4. Clinical supply chain strategy and plan for Phase 3 (transferred generally at start of Phase 3)
Accountable to the Global Program Team (GPT) for maintaining and delivering all aspects of the pharmaceutical development plan including control of the scope, timing, resources, cost, quality and risk
An active member of the GPT, contributing to the development of overall project strategies. Is expected to have credibility and influence within the team in which the role holder is a member
Accountable for the technical development strategy for APl, DP & Analytical aligned with project strategy and priority
The role involves a diverse range of problems/opportunities requiring complex judgements and solutions based on highly developed levels of conceptual thought and strategic vision and analysis
May represent CMC on the evaluation of business development opportunities
Has the responsibility to ensure that project strategies are reviewed

Qualification

CMC leadershipPharmaceutical strategyProject managementRegulatory strategyNegotiation skillsInterpersonal skillsCoaching skillsLearning agilityTeam leadershipCommunication skills

Required

10+ years experience in product development and manufacturing
Demonstrated strong leadership with enterprise mindset, learning agility, networking and negotiation skills and collaborative approach supportive of delivery of business objectives
Demonstrated strong interpersonal and communication skills with ability to set clear direction and objectives for the team and to influence at a senior level in the organization including Governance groups
Capable of managing the responsibilities for a diverse range of activities and projects acting as the key sponsor for projects and programs supporting their project portfolio
Excellent negotiation and influencing skills in order to influence and contribute to the cross-functional project/product strategies and deliverables
Possess strength and independence of viewpoint and be willing to challenge others in senior roles in other parts of Global Operations and the rest of the business when appropriate
Ability to develop & implement end-to-end Pharmaceutical strategy across all CMC areas (APl, DP, etc.) aligned with the overall GPT strategy and clinical/commercial supply
Significant experience of leading multi-disciplinary teams with an ability to ensure correct structure and team composition for efficient delivery and transition across the value stream
Strong coaching and motivational leadership skills that support the development of and delivery through the Pharmaceutical Team

Preferred

Advanced degree in Biochemistry, Pharmaceutical Chemistry, Pharmaceutics, Pharmaceutical Science, Chemical Engineering or related scientific discipline
PMP certification

Benefits

Qualified retirement programs
Paid time off (i.e., vacation, holiday, and leaves)
Health, dental, and vision coverage in accordance with the terms of the applicable plans

Company

Fusion Pharmaceuticals

twittertwittertwitter
company-logo
Fusion Pharmaceuticals is a clinical-stage oncology company focused on developing radiopharmaceuticals.

Funding

Current Stage
Public Company
Total Funding
$230.91M
Key Investors
CPP InvestmentsJohnson & Johnson Development Corporation
2024-03-19Acquired
2023-02-13Post Ipo Equity· $60M
2020-06-25IPO

Leadership Team

leader-logo
Dmitri Bobilev
Chief Medical Officer
linkedin
leader-logo
Eric Burak
Chief Technical Officer
linkedin
Company data provided by crunchbase